N-0164 inhibits generation of thromboxane-A2-like activity from prostaglandin endoperoxides by human platelet microsomes.
D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000378:metabolism; D001095:Arachidonic Acids / Q000494:pharmacology; D001792:Blood Platelets / Q000201:enzymology*; D006801:Humans; D006880:Hydroxy Acids / Q000302:isolation & purification / Q000378:metabolism*; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008861:Microsomes / Q000201:enzymology*; D009119:Muscle Contraction / Q000187:drug effects; D063065:Organophosphonates; D010545:Peroxides / Q000378:metabolism*; D011448:Prostaglandin Antagonists / Q000494:pharmacology*; D011453:Prostaglandins / Q000378:metabolism*; D011714:Pyrans / Q000302:isolation & purification / Q000378:metabolism*; D011817:Rabbits; D051381:Rats; D013270:Stomach / Q000187:drug effects
D001095:Arachidonic Acids; D006880:Hydroxy Acids; D063065:Organophosphonates; D010545:Peroxides; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D011714:Pyrans; C012641:N 0164; D007213:Indomethacin